1. Home
  2. ROIV vs EXPD Comparison

ROIV vs EXPD Comparison

Compare ROIV & EXPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$28.21

Market Cap

21.0B

Sector

Health Care

ML Signal

HOLD

Logo Expeditors International of Washington Inc.

EXPD

Expeditors International of Washington Inc.

HOLD

Current Price

$157.11

Market Cap

21.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
EXPD
Founded
2014
1979
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil Refining/Marketing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
21.0B
21.1B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
ROIV
EXPD
Price
$28.21
$157.11
Analyst Decision
Strong Buy
Hold
Analyst Count
9
11
Target Price
$28.94
$133.00
AVG Volume (30 Days)
5.8M
957.5K
Earning Date
05-28-2026
05-05-2026
Dividend Yield
N/A
1.03%
EPS Growth
N/A
4.02
EPS
N/A
1.71
Revenue
$8,260,000.00
$6,920,948,000.00
Revenue This Year
N/A
$2.71
Revenue Next Year
$744.61
$3.74
P/E Ratio
N/A
$93.58
Revenue Growth
N/A
13.49
52 Week Low
$10.71
$110.48
52 Week High
$32.79
$167.19

Technical Indicators

Market Signals
Indicator
ROIV
EXPD
Relative Strength Index (RSI) 44.33 54.22
Support Level $26.95 $148.95
Resistance Level $30.10 $165.83
Average True Range (ATR) 1.10 3.55
MACD -0.15 -0.17
Stochastic Oscillator 7.69 56.95

Price Performance

Historical Comparison
ROIV
EXPD

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About EXPD Expeditors International of Washington Inc.

Based in the US, Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2025, Expeditors derived 36% of consolidated gross revenue from airfreight, 25% from ocean freight, and 39% from customs brokerage and other services.

Share on Social Networks: